Study ADI-PEG 20 Plus Pembrolizumab in Advanced Solid Cancers
Clinical trial NCT03254732 · TERMINATED
Trial details
- NCT number
- NCT03254732
- Sponsor
- Polaris Group
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-14
- Primary completion
- 2019-05-07
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.